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Abstract
We report a case of type I Arnold-Chiari malformation that is veryIntroduction: 
peculiar because of its particular onset especially characterized by psychiatric
symptoms. These symptoms were so prevailing that, for fifteen years, they
masked the neurological aspects and the patient was treated with high doses of
psychotropic drugs without any benefit. If the Arnold-Chiari malformation had
been diagnosed before the development of severe hydro-syringomyelia, the
patient could have underwent decompressive neurosurgery which may have
improved her quality of life. 
It is worthwhile to highlight that psychotic symptoms may be caused by this
congenital malformation, that typically has an aspecific onset. Therefore it’s
important to consider an eventual organic etiology while challenging a resistant
clinical picture with unusual presentation.
 A 51-year-old woman reported neurological symptomsCase description:
consisting of headaches, blurred vision, diplopia, tinnitus, vertigo and
psychiatric symptoms including obsessive ideas about the fear of killing her
son, auditory and visual pseudo-hallucinations. The symptoms had developed
suddenly at the age of 35 years and persisted thereafter. She underwent
multiple hospitalizations in psychiatric units and was treated with a variety of
psychopharmacological approaches without substantial improvement. We
performed a brain MRI that identified a type I Arnold-Chiari malformation. We
assessed psychiatric symptoms using the Structured Clinical Interview for DSM
IV Axis I Disorders, the Brief Psychiatric Rating Scale, and the Yale-Brown
Obsessive-Compulsive Scale. A tailored psychopharmacological therapy led to
a partial improvement in mood and anxiety but not in hallucinations.
We want to highlight how important is, in everyday psychiatricDiscussion: 
clinical practice, not to focus only on psychiatric aspects but consider the
patient globally, because in this case psychiatric problems were the onset
presentation of a rare neurological syndrome.
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Introduction
Arnold-Chiari malformation (ACM) is a congenital brain anomaly 
characterized by herniation of the cerebellar structures through 
the foramen magnum. Its prevalence ranges from 0.2 to 1%1. It is 
characterized by four subtypes: type I consists of cerebellar tonsil 
herniation, which may be associated with syringohydromyelia, 
skull base alterations and hydrocephalus; in type II the herniation 
also involves the contents of the posterior fossa and it’s frequently 
associated with myelomeningocele and hydrocephalus2; ACM type 
III and IV are sporadic and characterized by the descent of both 
the cerebellum and brainstem into the spine and internal sac; and 
type IV is associated with cerebellar atrophy3. In Arnold-Chiari 
malformation type I and II, symptom onset is delayed until about 
the third decade4. General symptoms and signs include headaches, 
dizziness, tinnitus, visual or oculomotor symptoms, dysphagia, 
trunk or extremity dysesthesias, ataxia and drop attack4. In addition, 
psychiatric complications like anxiety and mood disorders are fre-
quent and affect the quality of life and the global functioning5. There 
is a paucity of literature pertaining to psychiatric illnesses associ-
ated with ACM and, to date, only three cases have been reported of 
an anxiety disorder in association with this specific malformation6–8 
and just two cases of ACM associated with psychotic features9,10.
Case description
We report the case of a 51-year-old woman, who was married and 
had a 23-year-old son.
She was hospitalized in December 2014 in the psychiatric depart-
ment of our hospital for persistent auditory hallucinations and visual 
pseudo-hallucinations together with headache, diplopia, tinnitus 
and vertigo. She was severely obese (BMI 34) and she was taking 
Olanzapine (30 mg/day), Duloxetine (90 mg/day), and Alprazolam 
(3 mg/day).
Since the age of 35, the patient had experienced headaches, ocu-
lomotor symptoms like blurred vision and diplopia, tinnitus and 
vertigo. These symptoms were so debilitating that she spent long 
periods of time lying in bed in a room with half-light and reduced 
noise. During the same period she started to experience psychiatric 
symptoms, at the beginning characterized by excessive anxiety, 
epigastric discomfort, restlessness and insomnia. Some months 
later she began to develop obsessive ideas about the fear of killing 
her son, who was 12-years-old at the time, without any compul-
sive behaviours. She also experienced auditory hallucinations with 
imperative voices and visual pseudo-hallucinations. In this period 
her mood was slightly depressed without suicidal intent.
Consequently, in 2001 at the age of 36, she was hospitalized in a 
psychiatric unit with the diagnosis of Schizophrenia. In the previous 
years she had never been hospitalized, there was no personal history 
of previous psychiatric disorders or substance misuse and also no 
family history of mental illness. The patient has a high school degree 
and since the age of 28 she worked as a secretary. During hospitaliza-
tion no abnormalities were found in blood parameters, electrocardi-
ography and urine analyses. She was prescribed Amisulpride tablets 
(300 mg/day) and Paroxetine tablets (40 mg/day), but after 5 days 
the patient developed extrapiramidal symptoms and akathisia. At 
this stage Amisulpride was discontinued and Haloperidol, orally 
administered at the dose of 6 mg/day was introduced. She experi-
enced only a partial benefit: hallucinations and obsessive ideas per-
sisted although the patient acknowledged an improvement in mood 
and anxiety. After 4 weeks she was discharged from the hospital 
and began follow-up outpatient care with a psychiatrist. Although 
she was treated sequentially with various antipsychotic drugs and 
antidepressants (Promazine, Aripiprazole, Olanzapine, Citalopram, 
Venlafaxine, Sertraline) she had only relative clinical improvements 
in mood and anxiety but not in hallucinations. She also continued to 
suffer from headaches, dizziness and tinnitus.
During the hospitalization in our unit, in consideration of the neuro-
logical symptoms, a brain MRI was performed. The results revealed a 
7 mm cerebellar tonsils herniation into the foramen magnum and the 
presence of an irregular cavity in the spinal cord, particularly between 
C4 and D1. An electroencephalograph (EEG) was inconclusive. 
A diagnosis of ACM-I with syringohydromyelia was established, 
the neurological assessment was within normal limits. We also had 
a consultation with the department of neurosurgery which ruled 
out the possibility of a decompression surgery because of the pres-
ence of a consolidated hydromyelia not likely to remit with sur-
gery. We assessed the psychiatric symptoms using the Structured 
Clinical Interview for DSM IV Axis I Disorders (SCID I) that, in 
consideration of the MRI result, was diagnostic for a Psychotic 
Disorder Due to Another Medical Condition11. We also adminis-
tered the Brief Psychiatric Rating Scale (BPRS, score: 30)12 and 
the Yale-Brown Obsessive-Compulsive Scale (YBOCS, score: 9)13. 
The decided treatment was: Risperidone tablets (3 mg/day; Olanza-
pine was withdrawn in consideration of the body weight), Sertra-
line tablets (150 mg/day) and Pregabalin tablets (100 mg/day). We 
observed that the patient underwent a substantial improvement in 
mood, insomnia, epigastric discomfort but she still did not experi-
ence a concrete improvement in obsessive ideas and hallucinations. 
The patient was discharged after three months of hospitalization in 
a low intensity psychiatric unit and, afterwards, began outpatient 
psychiatric and neurological follow-up.
Discussion and conclusions
In this report we aimed to present the case of a patient with a pecu-
liar presentation of ACM in which there is a paucity of neurological 
signs and symptoms and a prevalence of psychiatric aspects. As 
a result the patient has always been treated as a pure psychiatric 
patient despite the lack of impact of various psychotropic drugs on 
her symptoms; the neuroimaging examination, in fact, came only 
recently. Although the presentation is characteristic of a psychiatric 
disorder, the presence of nonspecific neurological symptoms should 
suggest a general medical condition causing psychiatric symptoms, 
especially in the absence of some of the most important “psychiatric 
clues” (such as family history, substance abuse or previous psychi-
atric subthreshold symptoms). To our knowledge, there is a lack of 
literature pertaining to psychiatric illnesses associated with ACM. In 
fact only three cases of an anxiety disorder in association with ACM 
have been reported to date6–8, and just two reports of ACM associated 
with psychotic features ( ACM association with epileptiform events10 
and with a major neurocognitive disorder11). Moreover, although 
anecdotal, some cases of ACM with psychotic features have already 
Page 2 of 3
F1000Research 2015, 4:915 Last updated: 28 SEP 2015
been described14. We decided to present this case because we consider 
mandatory not to underestimate the psychiatric symptomatology and 
to perform global investigations, particularly of neuroradiological 
nature. We believe, indeed, that the patient’s psychotic symptoms, 
especially auditory hallucinations and visual pseudo-hallucinations, 
are due to the organic pathology. It’s clearly understandable that this 
type of symptomatology, especially if unrecognized, may have led to 
a worsening of the anxious and depressive aspects.
Consent
Written informed consent for publication of their clinical details 
was obtained from the patient.
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